U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C4H7NO4
Molecular Weight 133.1027
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ASPARTIC ACID, DL-

SMILES

NC(CC(O)=O)C(O)=O

InChI

InChIKey=CKLJMWTZIZZHCS-UHFFFAOYSA-N
InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)

HIDE SMILES / InChI

Molecular Formula C4H7NO4
Molecular Weight 133.1027
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

PubMed

PubMed

TitleDatePubMed
Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.
2001-04-27
Identification and characterization of asporin. a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan.
2001-04-13
A splice variant of beta-secretase deficient in the amyloidogenic processing of the amyloid precursor protein.
2001-04-13
Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production.
2001-04-06
Large inter-experiment variations in microdialysate aspartate and glutamate in rat striatum may reflect a circannual rhythm.
2001-03-01
Evidence for microvesicular storage and release of glycine in rodent pinealocytes.
2001-02-16
Abnormal secretion and function of recombinant human factor VII as the result of modification to a calcium binding site caused by a 15-base pair insertion in the F7 gene.
2001-02-15
Pulmonary endothelinergic system in experimental congestive heart failure.
2001-02-01
Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
2001-02-01
An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma.
2001-02
Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3).
2001-02
Aldehyde dehydrogenase. Maintaining critical active site geometry at motif 8 in the class 3 enzyme.
2001-02
Effects of pressure on the activity and spectroscopic properties of carboxyl proteinases. Apparent correlation of pepstatin-insensitivity and pressure response.
2001-02
Extracellular amino acid levels measured with intracerebral microdialysis in the model of posttraumatic epilepsy induced by intracortical iron injection.
2001-02
Effect of an antisense oligodeoxynucleotide to endothelin-converting enzyme-1c (ECE-1c) on ECE-1c mRNA, ECE-1 protein and endothelin-1 synthesis in bovine pulmonary artery smooth muscle cells.
2001-02
The binding-site crevice of the D4 dopamine receptor is coupled to three distinct sites of allosteric modulation.
2001-02
PreproTRH(178-199) and two novel peptides (pFQ7 and pSE14) derived from its processing, which are produced in the paraventricular nucleus of the rat hypothalamus, are regulated during suckling.
2001-02
A signal sequence is sufficient for green fluorescent protein to be routed to regulated secretory granules.
2001-02
Reproducibility of hippocampal single-Voxel proton MR spectroscopy and chemical shift imaging.
2001-02
Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero.
2001-02
Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
2001-02
Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus.
2001-02
Direct evidence for the protonation of aspartate-75, proposed to be at a quinol binding site, upon reduction of cytochrome bo3 from Escherichia coli.
2001-01-30
Probing the relative timing of hydrogen abstraction steps in the flavocytochrome b2 reaction with primary and solvent deuterium isotope effects and mutant enzymes.
2001-01-30
Interloop contacts modulate ligand cycling during catalysis by Escherichia coli dihydrofolate reductase.
2001-01-30
Blockade of PKC epsilon activation attenuates phorbol ester-induced increase of alpha-secretase-derived secreted form of amyloid precursor protein.
2001-01-26
K-ras mutations in mouse lung tumors of extreme age: independent of paternal preconceptional exposure to chromium(III) but significantly more frequent in carcinomas than adenomas.
2001-01-25
Engineering conformational flexibility in the lactose permease of Escherichia coli: use of glycine-scanning mutagenesis to rescue mutant Glu325-->Asp.
2001-01-23
Bovine herpesvirus 1 glycoprotein G is required for prevention of apoptosis and efficient viral growth in rabbit kidney cells.
2001-01-20
Site-directed mutagenesis of the bacterial metalloamidase UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC). Identification of the zinc binding site.
2001-01-16
Interactions between yeast iso-1-cytochrome c and its peroxidase.
2001-01-16
Proteolysis of human hemoglobin by schistosome cathepsin D.
2001-01-15
Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo.
2001-01-05
The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia.
2001-01-01
aspS encoding an unusual aspartyl protease from Sclerotinia sclerotiorum is expressed during phytopathogenesis.
2001-01-01
Ehlers-Danlos syndrome type IV with a unique point mutation in COL3A1 and familial phenotype of myocardial infarction without organic coronary stenosis.
2001-01
MR diffusion imaging and 1H spectroscopy in a child with medulloblastoma. A case report.
2001-01
Lactococcus lactis LM0230 contains a single aminotransferase involved in aspartate biosynthesis, which is essential for growth in milk.
2001-01
Gene amplification in fibroblasts from ataxia telangiectasia (AT) patients and in X-ray hypersensitive AT-like Chinese hamster mutants.
2001-01
Proton MR spectroscopy in patients with acute temporal lobe seizures.
2001-01
Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: correlation with clinical outcome after traumatic brain injury.
2001-01
Development and aging of the cerebrum: assessment with proton MR spectroscopy.
2001-01
Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study.
2001-01
Two types of putative nuclear factors that physically interact with histidine-containing phosphotransfer (Hpt) domains, signaling mediators in His-to-Asp phosphorelay, in Arabidopsis thaliana.
2001-01
Na+/H+ antiporter from Synechocystis species PCC 6803, homologous to SOS1, contains an aspartic residue and long C-terminal tail important for the carrier activity.
2001-01
Chronic maternal smoking and cord blood amino acid and enzyme levels at term.
2001-01
Redistribution of neuroactive amino acids in hippocampus and striatum during hypoglycemia: a quantitative immunogold study.
2001-01
Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse.
2001-01
Possible linkage between glutamate transporter and mitogen-activated protein kinase cascade in cultured rat cortical astrocytes.
2001-01
Characterization of the protective effects of melatonin and related indoles against alpha-naphthylisothiocyanate-induced liver injury in rats.
2001
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:51:38 GMT 2025
Edited
by admin
on Mon Mar 31 17:51:38 GMT 2025
Record UNII
28XF4669EP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ASPARTIC ACID, DL-
Common Name English
DL-ASPARTIC ACID
FCC  
Preferred Name English
DL-ASPARTIC ACID [FCC]
Common Name English
DL-ASPARAGIC ACID
Common Name English
DL-AMINOSUCCINIC ACID
Common Name English
ACID D,L-ASPART
Common Name English
NSC-141379
Code English
ASPARTIC ACID (DL)
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID30859003
Created by admin on Mon Mar 31 17:51:38 GMT 2025 , Edited by admin on Mon Mar 31 17:51:38 GMT 2025
PRIMARY
ECHA (EC/EINECS)
210-513-3
Created by admin on Mon Mar 31 17:51:38 GMT 2025 , Edited by admin on Mon Mar 31 17:51:38 GMT 2025
PRIMARY
CAS
617-45-8
Created by admin on Mon Mar 31 17:51:38 GMT 2025 , Edited by admin on Mon Mar 31 17:51:38 GMT 2025
PRIMARY
NSC
141379
Created by admin on Mon Mar 31 17:51:38 GMT 2025 , Edited by admin on Mon Mar 31 17:51:38 GMT 2025
PRIMARY
FDA UNII
28XF4669EP
Created by admin on Mon Mar 31 17:51:38 GMT 2025 , Edited by admin on Mon Mar 31 17:51:38 GMT 2025
PRIMARY
CHEBI
22660
Created by admin on Mon Mar 31 17:51:38 GMT 2025 , Edited by admin on Mon Mar 31 17:51:38 GMT 2025
PRIMARY
PUBCHEM
424
Created by admin on Mon Mar 31 17:51:38 GMT 2025 , Edited by admin on Mon Mar 31 17:51:38 GMT 2025
PRIMARY
SMS_ID
100000145092
Created by admin on Mon Mar 31 17:51:38 GMT 2025 , Edited by admin on Mon Mar 31 17:51:38 GMT 2025
PRIMARY
EVMPD
SUB122916
Created by admin on Mon Mar 31 17:51:38 GMT 2025 , Edited by admin on Mon Mar 31 17:51:38 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY